Show simple item record

dc.contributor.authorHannon, C
dc.contributor.authorCruz-Migoni, A
dc.contributor.authorPlatonova, O
dc.contributor.authorOwen, RL
dc.contributor.authorNettleship, JE
dc.contributor.authorMiller, A
dc.contributor.authorCarr, SB
dc.contributor.authorHarris, G
dc.contributor.authorRabbitts, TH
dc.contributor.authorPhillips, SEV
dc.date.accessioned2020-12-21T14:05:20Z
dc.date.issued2018-03-01
dc.identifier.citationActa crystallographica. Section F, Structural biology communications, 2018, 74 (Pt 3), pp. 143 - 149
dc.identifier.issn2053-230X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4261
dc.identifier.eissn2053-230X
dc.identifier.doi10.1107/s2053230x18001553
dc.description.abstractLens epithelium-derived growth factor (LEDGF)/p75 is the dominant binding partner of HIV-1 integrase in human cells. The crystal structure of the HIV integrase-binding domain (IBD) of LEDGF has been determined in the absence of ligand. IBD was overexpressed in Escherichia coli, purified and crystallized by sitting-drop vapour diffusion. X-ray diffraction data were collected at Diamond Light Source to a resolution of 2.05 Å. The crystals belonged to space group P21, with eight polypeptide chains in the asymmetric unit arranged as an unusual octamer composed of four domain-swapped IBD dimers. IBD exists as a mixture of monomers and dimers in concentrated solutions, but the dimers are unlikely to be biologically relevant.
dc.formatPrint-Electronic
dc.format.extent143 - 149
dc.languageeng
dc.language.isoeng
dc.publisherINT UNION CRYSTALLOGRAPHY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectHIV Integrase
dc.subjectAdaptor Proteins, Signal Transducing
dc.subjectTranscription Factors
dc.subjectCrystallization
dc.subjectCrystallography, X-Ray
dc.subjectAmino Acid Sequence
dc.subjectCatalytic Domain
dc.subjectProtein Conformation
dc.subjectModels, Molecular
dc.titleCloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor.
dc.typeJournal Article
dcterms.dateAccepted2018-01-23
rioxxterms.versionofrecord10.1107/s2053230x18001553
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfActa crystallographica. Section F, Structural biology communications
pubs.issuePt 3
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Chromosomal Translocations and Intracellular Antibody Therapeutics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Chromosomal Translocations and Intracellular Antibody Therapeutics
pubs.publication-statusPublished
pubs.volume74
pubs.embargo.termsNot known
icr.researchteamChromosomal Translocations and Intracellular Antibody Therapeutics
dc.contributor.icrauthorRabbitts, Terence


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0